Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 51 | 2024 | 11101 | 2.190 |
Why?
|
Gonadotropin-Releasing Hormone | 19 | 2024 | 1149 | 1.650 |
Why?
|
Antineoplastic Agents, Hormonal | 15 | 2013 | 1536 | 1.250 |
Why?
|
Testicular Neoplasms | 42 | 2007 | 806 | 1.210 |
Why?
|
Androgen Antagonists | 17 | 2024 | 1412 | 0.990 |
Why?
|
Oligopeptides | 11 | 2011 | 1194 | 0.880 |
Why?
|
Names | 2 | 2013 | 54 | 0.840 |
Why?
|
Prostate-Specific Antigen | 16 | 2013 | 2463 | 0.830 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 17 | 2007 | 498 | 0.810 |
Why?
|
Patient Preference | 3 | 2014 | 946 | 0.770 |
Why?
|
Finasteride | 1 | 2019 | 86 | 0.610 |
Why?
|
Androstenes | 1 | 2019 | 177 | 0.590 |
Why?
|
Pyrroles | 2 | 2014 | 1123 | 0.590 |
Why?
|
Carcinoma, Renal Cell | 6 | 2014 | 3187 | 0.570 |
Why?
|
Antineoplastic Agents | 25 | 2014 | 13658 | 0.560 |
Why?
|
Kidney Neoplasms | 10 | 2014 | 4282 | 0.530 |
Why?
|
Testosterone | 10 | 2015 | 2491 | 0.520 |
Why?
|
Indoles | 2 | 2014 | 1835 | 0.520 |
Why?
|
Sulfonamides | 2 | 2014 | 1982 | 0.460 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 15660 | 0.460 |
Why?
|
Leuprolide | 10 | 2011 | 313 | 0.420 |
Why?
|
Tosyl Compounds | 3 | 2012 | 115 | 0.410 |
Why?
|
Marketing | 1 | 2015 | 224 | 0.410 |
Why?
|
Drug Labeling | 1 | 2015 | 250 | 0.400 |
Why?
|
Nitriles | 4 | 2019 | 980 | 0.400 |
Why?
|
Azasteroids | 1 | 2012 | 37 | 0.390 |
Why?
|
Pyrimidines | 2 | 2014 | 3046 | 0.390 |
Why?
|
Anilides | 3 | 2012 | 413 | 0.380 |
Why?
|
Follicle Stimulating Hormone | 6 | 2017 | 727 | 0.370 |
Why?
|
Niacinamide | 1 | 2013 | 418 | 0.370 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2012 | 112 | 0.350 |
Why?
|
Phenylurea Compounds | 1 | 2013 | 531 | 0.340 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 23 | 2012 | 11873 | 0.340 |
Why?
|
Orchiectomy | 8 | 2017 | 466 | 0.330 |
Why?
|
Hormone Replacement Therapy | 1 | 2015 | 757 | 0.320 |
Why?
|
Erythropoietin | 2 | 2010 | 718 | 0.320 |
Why?
|
Hypogonadism | 1 | 2015 | 805 | 0.310 |
Why?
|
Taxoids | 1 | 2012 | 665 | 0.310 |
Why?
|
Dysgerminoma | 13 | 1989 | 66 | 0.310 |
Why?
|
Drug Industry | 1 | 2015 | 791 | 0.300 |
Why?
|
Mass Screening | 4 | 2012 | 5458 | 0.290 |
Why?
|
Quinolines | 1 | 2013 | 770 | 0.290 |
Why?
|
Prostatectomy | 3 | 2010 | 1786 | 0.290 |
Why?
|
Male | 130 | 2024 | 364641 | 0.290 |
Why?
|
Delayed-Action Preparations | 4 | 2006 | 968 | 0.290 |
Why?
|
Prostatic Hyperplasia | 1 | 2012 | 516 | 0.290 |
Why?
|
Drug Approval | 1 | 2015 | 820 | 0.290 |
Why?
|
Colony-Stimulating Factors | 5 | 1990 | 218 | 0.290 |
Why?
|
Goserelin | 2 | 2011 | 126 | 0.270 |
Why?
|
Macrophage Colony-Stimulating Factor | 7 | 1996 | 186 | 0.270 |
Why?
|
Retroperitoneal Neoplasms | 4 | 2007 | 335 | 0.260 |
Why?
|
Estrogens | 2 | 2012 | 1536 | 0.250 |
Why?
|
Physician-Patient Relations | 2 | 2018 | 3269 | 0.240 |
Why?
|
Lymph Node Excision | 5 | 2007 | 1269 | 0.220 |
Why?
|
Doxorubicin | 14 | 1989 | 2234 | 0.220 |
Why?
|
Diethylstilbestrol | 4 | 1997 | 85 | 0.220 |
Why?
|
Neoadjuvant Therapy | 2 | 2013 | 2902 | 0.210 |
Why?
|
Teratoma | 8 | 1991 | 405 | 0.210 |
Why?
|
Humans | 155 | 2024 | 767991 | 0.210 |
Why?
|
Neoplasm Metastasis | 10 | 2020 | 4904 | 0.200 |
Why?
|
Neoplasm, Residual | 1 | 2007 | 1014 | 0.200 |
Why?
|
Cisplatin | 19 | 1992 | 1658 | 0.190 |
Why?
|
Peptides | 2 | 2006 | 4354 | 0.190 |
Why?
|
Carcinoma, Transitional Cell | 4 | 1998 | 794 | 0.180 |
Why?
|
Urinary Bladder Neoplasms | 7 | 1998 | 2195 | 0.180 |
Why?
|
Androgens | 3 | 2024 | 1281 | 0.170 |
Why?
|
Polymers | 1 | 2006 | 1627 | 0.160 |
Why?
|
Phenylthiohydantoin | 1 | 2019 | 207 | 0.150 |
Why?
|
Bleomycin | 11 | 1992 | 492 | 0.140 |
Why?
|
Luteinizing Hormone | 5 | 2006 | 822 | 0.140 |
Why?
|
Recombinant Proteins | 12 | 2010 | 6515 | 0.140 |
Why?
|
Streptozocin | 4 | 1987 | 190 | 0.140 |
Why?
|
Physicians | 1 | 2015 | 4598 | 0.140 |
Why?
|
Receptors, LHRH | 1 | 2017 | 158 | 0.130 |
Why?
|
Testis | 3 | 2001 | 783 | 0.120 |
Why?
|
Vinblastine | 12 | 1992 | 487 | 0.120 |
Why?
|
Cholesterol | 6 | 2006 | 2914 | 0.120 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2230 | 0.120 |
Why?
|
Preoperative Care | 2 | 2010 | 2256 | 0.120 |
Why?
|
Neoplasm Staging | 18 | 2013 | 11221 | 0.110 |
Why?
|
Conflict of Interest | 1 | 1999 | 556 | 0.110 |
Why?
|
Combined Modality Therapy | 12 | 2013 | 8535 | 0.110 |
Why?
|
Injections, Intramuscular | 4 | 2004 | 554 | 0.110 |
Why?
|
Interleukin-3 | 3 | 1990 | 425 | 0.110 |
Why?
|
Benzamides | 1 | 2019 | 1377 | 0.110 |
Why?
|
Radiotherapy | 6 | 2012 | 1501 | 0.110 |
Why?
|
Empathy | 1 | 2018 | 474 | 0.110 |
Why?
|
Hormones | 2 | 1987 | 866 | 0.100 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6119 | 0.100 |
Why?
|
Half-Life | 2 | 2004 | 651 | 0.100 |
Why?
|
Indazoles | 1 | 2014 | 306 | 0.100 |
Why?
|
Dihydrotestosterone | 2 | 2004 | 195 | 0.100 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1883 | 0.100 |
Why?
|
Retroperitoneal Space | 4 | 2007 | 175 | 0.090 |
Why?
|
Aged | 40 | 2015 | 171446 | 0.090 |
Why?
|
Mediastinal Neoplasms | 2 | 1985 | 403 | 0.090 |
Why?
|
Anemia | 2 | 2010 | 1514 | 0.090 |
Why?
|
Middle Aged | 53 | 2015 | 223422 | 0.090 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2018 | 1374 | 0.090 |
Why?
|
Advisory Committees | 1 | 2015 | 797 | 0.090 |
Why?
|
Drug Evaluation | 10 | 1989 | 642 | 0.090 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2000 | 3553 | 0.080 |
Why?
|
Sexual Dysfunction, Physiological | 3 | 2007 | 364 | 0.080 |
Why?
|
Area Under Curve | 2 | 2004 | 1642 | 0.080 |
Why?
|
Leukemia | 3 | 1991 | 1519 | 0.080 |
Why?
|
Risk Factors | 5 | 2024 | 74936 | 0.080 |
Why?
|
Erectile Dysfunction | 1 | 2012 | 437 | 0.080 |
Why?
|
Buserelin | 1 | 1988 | 16 | 0.080 |
Why?
|
Urinary Incontinence | 1 | 2012 | 490 | 0.070 |
Why?
|
Choriocarcinoma | 3 | 1983 | 121 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3589 | 0.070 |
Why?
|
Bone Neoplasms | 3 | 2017 | 2564 | 0.070 |
Why?
|
Watchful Waiting | 1 | 2010 | 492 | 0.070 |
Why?
|
Adult | 57 | 2015 | 223583 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1671 | 0.070 |
Why?
|
Medication Adherence | 1 | 2018 | 2187 | 0.070 |
Why?
|
Leukocytes | 3 | 1992 | 2035 | 0.070 |
Why?
|
Anthraquinones | 2 | 1983 | 41 | 0.070 |
Why?
|
Digestive System | 2 | 1984 | 244 | 0.070 |
Why?
|
Clinical Trials as Topic | 8 | 2000 | 8052 | 0.060 |
Why?
|
Aging | 1 | 2004 | 8744 | 0.060 |
Why?
|
Polyglycolic Acid | 1 | 2006 | 408 | 0.060 |
Why?
|
Neoplasms, Multiple Primary | 3 | 1991 | 594 | 0.060 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 1984 | 68 | 0.060 |
Why?
|
Solubility | 1 | 2006 | 1083 | 0.060 |
Why?
|
Thrombocytopenia | 4 | 1996 | 1179 | 0.060 |
Why?
|
Cyclophosphamide | 7 | 1990 | 2227 | 0.060 |
Why?
|
Quality of Life | 4 | 2023 | 13489 | 0.060 |
Why?
|
Lymphatic Metastasis | 8 | 1988 | 2908 | 0.060 |
Why?
|
Chorionic Gonadotropin | 3 | 1988 | 458 | 0.060 |
Why?
|
Methotrexate | 7 | 1989 | 1721 | 0.060 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2006 | 639 | 0.060 |
Why?
|
Adenocarcinoma | 10 | 2003 | 6371 | 0.050 |
Why?
|
Thromboembolism | 1 | 2010 | 1003 | 0.050 |
Why?
|
Metoclopramide | 1 | 1983 | 51 | 0.050 |
Why?
|
Breast Neoplasms | 4 | 2010 | 21206 | 0.050 |
Why?
|
Hormone Antagonists | 1 | 2003 | 108 | 0.050 |
Why?
|
Aged, 80 and over | 9 | 2011 | 59598 | 0.050 |
Why?
|
Biological Availability | 1 | 2004 | 389 | 0.050 |
Why?
|
Drug Therapy, Combination | 8 | 1999 | 6314 | 0.050 |
Why?
|
Bone Marrow Diseases | 1 | 1985 | 234 | 0.050 |
Why?
|
Female | 40 | 2014 | 397113 | 0.050 |
Why?
|
Metabolic Clearance Rate | 1 | 2003 | 363 | 0.050 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2006 | 878 | 0.050 |
Why?
|
Survival Analysis | 2 | 2010 | 10098 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1991 | 2204 | 0.050 |
Why?
|
Employment | 3 | 1999 | 1110 | 0.050 |
Why?
|
Genital Diseases, Male | 1 | 1982 | 84 | 0.050 |
Why?
|
Bile | 3 | 1977 | 299 | 0.050 |
Why?
|
Scrotum | 1 | 1982 | 117 | 0.050 |
Why?
|
Maternal-Fetal Exchange | 1 | 1983 | 454 | 0.050 |
Why?
|
Lactic Acid | 1 | 2006 | 1140 | 0.050 |
Why?
|
Prognosis | 4 | 2010 | 29979 | 0.050 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 1983 | 260 | 0.050 |
Why?
|
Pancreatitis | 1 | 1988 | 1087 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2017 | 3433 | 0.050 |
Why?
|
Attitude to Health | 1 | 1989 | 2024 | 0.040 |
Why?
|
Dwarfism | 1 | 1981 | 137 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2006 | 1196 | 0.040 |
Why?
|
United States | 4 | 2015 | 73027 | 0.040 |
Why?
|
Glaucarubin | 1 | 1979 | 3 | 0.040 |
Why?
|
Receptors, FSH | 1 | 2000 | 29 | 0.040 |
Why?
|
Fasting | 1 | 2006 | 1609 | 0.040 |
Why?
|
Brachytherapy | 2 | 1998 | 1220 | 0.040 |
Why?
|
Serum Globulins | 1 | 1979 | 23 | 0.040 |
Why?
|
Thyroxine-Binding Proteins | 1 | 1979 | 24 | 0.040 |
Why?
|
Hypercalcemia | 2 | 1980 | 424 | 0.040 |
Why?
|
Leukocyte Count | 4 | 1992 | 1609 | 0.040 |
Why?
|
Pyrans | 1 | 1979 | 49 | 0.040 |
Why?
|
Interferon-gamma | 1 | 1988 | 3159 | 0.040 |
Why?
|
Interleukin-6 | 1 | 1989 | 3228 | 0.040 |
Why?
|
Fever | 2 | 1984 | 1613 | 0.040 |
Why?
|
Penicillin G Procaine | 1 | 1978 | 4 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2003 | 707 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2023 | 81746 | 0.040 |
Why?
|
Risk Assessment | 2 | 2010 | 24314 | 0.040 |
Why?
|
Prospective Studies | 9 | 2011 | 54924 | 0.040 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 2 | 1990 | 306 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2012 | 15831 | 0.040 |
Why?
|
Macaca fascicularis | 5 | 1992 | 912 | 0.040 |
Why?
|
Indians, North American | 2 | 1979 | 354 | 0.040 |
Why?
|
Carcinoma in Situ | 1 | 1984 | 788 | 0.040 |
Why?
|
Asparaginase | 1 | 1979 | 240 | 0.040 |
Why?
|
Penile Neoplasms | 1 | 1979 | 158 | 0.040 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2000 | 409 | 0.040 |
Why?
|
Time Factors | 10 | 2010 | 40214 | 0.040 |
Why?
|
Phenobarbital | 1 | 1977 | 192 | 0.030 |
Why?
|
Skin Tests | 1 | 1978 | 630 | 0.030 |
Why?
|
Lymphoma | 4 | 1983 | 1897 | 0.030 |
Why?
|
Interleukin-11 | 1 | 1996 | 59 | 0.030 |
Why?
|
Eye Diseases | 1 | 1981 | 660 | 0.030 |
Why?
|
Hematopoiesis | 3 | 1990 | 2059 | 0.030 |
Why?
|
Adolescent | 24 | 1996 | 89155 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1979 | 617 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 1979 | 644 | 0.030 |
Why?
|
Acid Phosphatase | 2 | 1986 | 141 | 0.030 |
Why?
|
Lung | 4 | 1992 | 10094 | 0.030 |
Why?
|
Predictive Value of Tests | 5 | 2013 | 15442 | 0.030 |
Why?
|
Radiation Monitoring | 1 | 1976 | 106 | 0.030 |
Why?
|
Follow-Up Studies | 8 | 2010 | 39345 | 0.030 |
Why?
|
Infusions, Parenteral | 4 | 1983 | 395 | 0.030 |
Why?
|
Incidence | 2 | 2007 | 21532 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7445 | 0.030 |
Why?
|
Cannabis | 1 | 1980 | 446 | 0.030 |
Why?
|
Sarcoidosis | 1 | 1980 | 535 | 0.030 |
Why?
|
Disease Progression | 3 | 2020 | 13665 | 0.030 |
Why?
|
Proteins | 2 | 2006 | 6009 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2000 | 1089 | 0.030 |
Why?
|
Etoposide | 2 | 1986 | 640 | 0.030 |
Why?
|
Neoplasms | 10 | 1991 | 22365 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 1987 | 2599 | 0.030 |
Why?
|
Leukemia, Myeloid | 2 | 1989 | 693 | 0.030 |
Why?
|
Rectal Neoplasms | 3 | 1983 | 1183 | 0.030 |
Why?
|
Bone Resorption | 1 | 2017 | 728 | 0.030 |
Why?
|
Hepatic Artery | 3 | 1984 | 232 | 0.030 |
Why?
|
Infusions, Intra-Arterial | 3 | 1983 | 220 | 0.030 |
Why?
|
Cell Division | 1 | 2000 | 4473 | 0.030 |
Why?
|
Acute Disease | 3 | 1989 | 7241 | 0.030 |
Why?
|
Fluorouracil | 3 | 1990 | 1652 | 0.030 |
Why?
|
Animals | 13 | 2017 | 169222 | 0.030 |
Why?
|
Leukemia, Lymphoid | 2 | 1985 | 311 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 7 | 1991 | 9412 | 0.020 |
Why?
|
History, 20th Century | 1 | 2020 | 2766 | 0.020 |
Why?
|
Bone Marrow Transplantation | 2 | 1991 | 2710 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 1976 | 1034 | 0.020 |
Why?
|
Research Support as Topic | 1 | 1996 | 696 | 0.020 |
Why?
|
Mitoguazone | 2 | 1982 | 11 | 0.020 |
Why?
|
Models, Biological | 2 | 2004 | 9493 | 0.020 |
Why?
|
Blood Glucose | 1 | 2006 | 6429 | 0.020 |
Why?
|
Leucovorin | 4 | 1983 | 643 | 0.020 |
Why?
|
Ureteral Obstruction | 3 | 1984 | 293 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1992 | 892 | 0.020 |
Why?
|
Prostate | 1 | 2000 | 1765 | 0.020 |
Why?
|
Infusions, Intravenous | 3 | 1996 | 2227 | 0.020 |
Why?
|
Survival Rate | 2 | 1998 | 12828 | 0.020 |
Why?
|
Cryptorchidism | 2 | 1982 | 153 | 0.020 |
Why?
|
Cryosurgery | 1 | 1996 | 479 | 0.020 |
Why?
|
Evaluation Studies as Topic | 5 | 1984 | 1625 | 0.020 |
Why?
|
Random Allocation | 2 | 1986 | 2396 | 0.020 |
Why?
|
Guanidines | 2 | 1982 | 194 | 0.020 |
Why?
|
Monocytes | 2 | 1990 | 2605 | 0.020 |
Why?
|
Drug Administration Schedule | 4 | 1988 | 4857 | 0.020 |
Why?
|
Technetium Tc 99m Medronate | 1 | 1990 | 136 | 0.020 |
Why?
|
Melanoma | 3 | 1996 | 5706 | 0.020 |
Why?
|
alpha-Fetoproteins | 2 | 1988 | 229 | 0.020 |
Why?
|
Drug Hypersensitivity | 1 | 1978 | 903 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 3 | 1992 | 1335 | 0.020 |
Why?
|
Research Design | 2 | 2000 | 6211 | 0.020 |
Why?
|
Cell Count | 2 | 1990 | 1831 | 0.020 |
Why?
|
Reference Values | 1 | 1996 | 4938 | 0.020 |
Why?
|
Silicone Elastomers | 1 | 1988 | 78 | 0.020 |
Why?
|
Lung Neoplasms | 5 | 1988 | 13499 | 0.020 |
Why?
|
Leukopenia | 3 | 1985 | 212 | 0.020 |
Why?
|
Ultrasonography | 1 | 1982 | 6004 | 0.020 |
Why?
|
Granuloma | 2 | 1988 | 329 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 1977 | 1904 | 0.020 |
Why?
|
Bile Acids and Salts | 4 | 1978 | 398 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 1990 | 1162 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 1990 | 1377 | 0.020 |
Why?
|
Liver Neoplasms | 2 | 1983 | 4362 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2006 | 65364 | 0.020 |
Why?
|
Vena Cava, Inferior | 2 | 1988 | 463 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 1998 | 1932 | 0.020 |
Why?
|
Cholelithiasis | 3 | 1978 | 408 | 0.020 |
Why?
|
Mesonephroma | 2 | 1983 | 21 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1991 | 1353 | 0.020 |
Why?
|
Macrophages | 3 | 1991 | 5799 | 0.020 |
Why?
|
Primates | 1 | 1989 | 520 | 0.020 |
Why?
|
Joint Prosthesis | 1 | 1988 | 251 | 0.020 |
Why?
|
Lymphatic Diseases | 1 | 1988 | 318 | 0.020 |
Why?
|
Floxuridine | 2 | 1983 | 44 | 0.020 |
Why?
|
Growth Substances | 1 | 1988 | 759 | 0.020 |
Why?
|
Rabbits | 2 | 1991 | 4771 | 0.020 |
Why?
|
Nausea | 3 | 1983 | 682 | 0.020 |
Why?
|
Mitoxantrone | 2 | 1983 | 148 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 8 | 1991 | 20757 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 1991 | 772 | 0.020 |
Why?
|
Lung Diseases | 2 | 1989 | 1944 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 1978 | 1942 | 0.020 |
Why?
|
Lymph Nodes | 4 | 1987 | 3472 | 0.020 |
Why?
|
Phospholipids | 3 | 1979 | 785 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2010 | 1622 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 1996 | 10396 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2010 | 2923 | 0.020 |
Why?
|
Diagnosis, Differential | 4 | 1996 | 13000 | 0.010 |
Why?
|
Fertility | 1 | 1989 | 771 | 0.010 |
Why?
|
Infertility, Male | 2 | 1985 | 397 | 0.010 |
Why?
|
Tomography, X-Ray | 1 | 1984 | 58 | 0.010 |
Why?
|
Spleen | 1 | 1991 | 2295 | 0.010 |
Why?
|
Liver Circulation | 1 | 1984 | 159 | 0.010 |
Why?
|
Physical Examination | 1 | 1990 | 1263 | 0.010 |
Why?
|
Menstruation | 2 | 1976 | 310 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 1991 | 1820 | 0.010 |
Why?
|
Podophyllotoxin | 1 | 1983 | 20 | 0.010 |
Why?
|
Dactinomycin | 1 | 1984 | 305 | 0.010 |
Why?
|
Cystitis | 1 | 1984 | 96 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1991 | 1308 | 0.010 |
Why?
|
Thrombocythemia, Essential | 1 | 1985 | 114 | 0.010 |
Why?
|
Solitary Pulmonary Nodule | 1 | 1987 | 281 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1979 | 4050 | 0.010 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 2003 | 82 | 0.010 |
Why?
|
Urinary Diversion | 1 | 1984 | 134 | 0.010 |
Why?
|
Leukemia, Radiation-Induced | 1 | 1983 | 36 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2017 | 3986 | 0.010 |
Why?
|
Bone Marrow | 4 | 1983 | 2935 | 0.010 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1982 | 144 | 0.010 |
Why?
|
Agranulocytosis | 1 | 1982 | 98 | 0.010 |
Why?
|
Thyroid Function Tests | 2 | 1983 | 289 | 0.010 |
Why?
|
Administration, Oral | 2 | 1983 | 4030 | 0.010 |
Why?
|
Behavior | 1 | 1985 | 541 | 0.010 |
Why?
|
Mitobronitol | 1 | 1981 | 3 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6228 | 0.010 |
Why?
|
Arizona | 2 | 1979 | 108 | 0.010 |
Why?
|
Educational Status | 1 | 1989 | 2515 | 0.010 |
Why?
|
Remission, Spontaneous | 2 | 1979 | 384 | 0.010 |
Why?
|
Lymphocytes | 1 | 1990 | 2614 | 0.010 |
Why?
|
Castration | 1 | 2001 | 149 | 0.010 |
Why?
|
Administration, Topical | 1 | 1984 | 703 | 0.010 |
Why?
|
Vinca Alkaloids | 1 | 1981 | 36 | 0.010 |
Why?
|
Graft vs Host Reaction | 1 | 1981 | 99 | 0.010 |
Why?
|
Fetal Death | 1 | 1983 | 434 | 0.010 |
Why?
|
Neoplastic Cells, Circulating | 1 | 1988 | 952 | 0.010 |
Why?
|
Catheters, Indwelling | 1 | 1984 | 436 | 0.010 |
Why?
|
Carcinoembryonic Antigen | 2 | 1982 | 338 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 1991 | 2403 | 0.010 |
Why?
|
Kidney Diseases | 2 | 1984 | 2100 | 0.010 |
Why?
|
Ureter | 1 | 1984 | 364 | 0.010 |
Why?
|
Estrogen Antagonists | 1 | 1981 | 151 | 0.010 |
Why?
|
Paraneoplastic Syndromes | 1 | 1982 | 154 | 0.010 |
Why?
|
Busulfan | 1 | 1981 | 259 | 0.010 |
Why?
|
Diet | 1 | 1998 | 8087 | 0.010 |
Why?
|
Liver | 2 | 1991 | 7574 | 0.010 |
Why?
|
Urogenital Neoplasms | 2 | 1980 | 130 | 0.010 |
Why?
|
Attitude | 1 | 1985 | 771 | 0.010 |
Why?
|
Neutrophils | 2 | 1990 | 3786 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6843 | 0.010 |
Why?
|
Quassins | 1 | 1979 | 6 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6517 | 0.010 |
Why?
|
Emotions | 2 | 1997 | 2766 | 0.010 |
Why?
|
Genital Neoplasms, Female | 1 | 1985 | 536 | 0.010 |
Why?
|
Perfusion | 1 | 1984 | 1401 | 0.010 |
Why?
|
Palpation | 1 | 1980 | 166 | 0.010 |
Why?
|
Homeostasis | 1 | 1991 | 3348 | 0.010 |
Why?
|
Social Support | 1 | 1989 | 2193 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 1998 | 36742 | 0.010 |
Why?
|
Heart | 2 | 1983 | 4444 | 0.010 |
Why?
|
Thyroid Diseases | 1 | 1983 | 385 | 0.010 |
Why?
|
Mucous Membrane | 1 | 1983 | 659 | 0.010 |
Why?
|
Radiography | 2 | 1988 | 6983 | 0.010 |
Why?
|
Tuberculin | 1 | 1979 | 64 | 0.010 |
Why?
|
Colonic Neoplasms | 2 | 1983 | 2540 | 0.010 |
Why?
|
Urethritis | 1 | 1978 | 30 | 0.010 |
Why?
|
Penicillin Resistance | 1 | 1978 | 77 | 0.010 |
Why?
|
Safety | 1 | 2003 | 1159 | 0.010 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 1983 | 542 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1979 | 863 | 0.010 |
Why?
|
Myeloproliferative Disorders | 1 | 1985 | 616 | 0.010 |
Why?
|
Myeloma Proteins | 1 | 1978 | 71 | 0.010 |
Why?
|
Astrocytoma | 1 | 1983 | 774 | 0.010 |
Why?
|
Dogs | 1 | 1983 | 3844 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 1985 | 1434 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1990 | 10757 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 1990 | 3409 | 0.010 |
Why?
|
Affect | 1 | 1985 | 1495 | 0.010 |
Why?
|
Methods | 1 | 1978 | 1066 | 0.010 |
Why?
|
Child | 6 | 1992 | 80906 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12075 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11068 | 0.010 |
Why?
|
Leydig Cells | 1 | 1996 | 55 | 0.010 |
Why?
|
Risk | 2 | 1986 | 9609 | 0.010 |
Why?
|
Colony-Forming Units Assay | 2 | 1990 | 351 | 0.010 |
Why?
|
Fetal Blood | 1 | 1983 | 1361 | 0.010 |
Why?
|
Apolipoproteins | 1 | 1979 | 328 | 0.010 |
Why?
|
Child, Preschool | 4 | 1992 | 42665 | 0.010 |
Why?
|
BCG Vaccine | 1 | 1979 | 381 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 1989 | 7851 | 0.010 |
Why?
|
Thyroxine | 1 | 1979 | 666 | 0.010 |
Why?
|
Seminoma | 1 | 1996 | 136 | 0.010 |
Why?
|
Sexual Behavior | 1 | 1985 | 2197 | 0.010 |
Why?
|
Radiation Injuries | 2 | 1984 | 1198 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 1996 | 686 | 0.010 |
Why?
|
Gallbladder | 1 | 1976 | 308 | 0.010 |
Why?
|
Placenta | 1 | 1983 | 1725 | 0.010 |
Why?
|
Lipoproteins | 1 | 1979 | 879 | 0.010 |
Why?
|
Contraceptives, Oral | 1 | 1976 | 560 | 0.010 |
Why?
|
Rats | 1 | 1990 | 23751 | 0.010 |
Why?
|
Hypotension | 1 | 1979 | 888 | 0.010 |
Why?
|
Hyperplasia | 1 | 1996 | 1151 | 0.010 |
Why?
|
Pain Measurement | 1 | 2003 | 3583 | 0.010 |
Why?
|
Mice | 1 | 2000 | 82024 | 0.010 |
Why?
|
Health Education | 1 | 1980 | 1059 | 0.010 |
Why?
|
Radionuclide Imaging | 2 | 1990 | 2000 | 0.010 |
Why?
|
Respiratory Burst | 1 | 1992 | 110 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 1981 | 1883 | 0.010 |
Why?
|
Fibroblasts | 1 | 1983 | 4176 | 0.010 |
Why?
|
Phenotype | 1 | 1990 | 16723 | 0.010 |
Why?
|
Uric Acid | 1 | 1978 | 805 | 0.010 |
Why?
|
Radiation Tolerance | 2 | 1984 | 476 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1988 | 4915 | 0.010 |
Why?
|
Triglycerides | 1 | 1979 | 2463 | 0.010 |
Why?
|
Binding Sites | 1 | 1979 | 6022 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1992 | 760 | 0.010 |
Why?
|
Vincristine | 2 | 1983 | 1040 | 0.010 |
Why?
|
Kidney | 3 | 1984 | 7065 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 1978 | 3618 | 0.010 |
Why?
|
Aerosols | 1 | 1992 | 634 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 1992 | 1169 | 0.010 |
Why?
|
Thyroid Neoplasms | 1 | 1983 | 2361 | 0.010 |
Why?
|
Toe Joint | 1 | 1988 | 19 | 0.000 |
Why?
|
Actuarial Analysis | 1 | 1989 | 370 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 1 | 1978 | 2258 | 0.000 |
Why?
|
Groin | 1 | 1988 | 106 | 0.000 |
Why?
|
Granulocytes | 1 | 1990 | 551 | 0.000 |
Why?
|
Data Collection | 1 | 1997 | 3326 | 0.000 |
Why?
|
Biotechnology | 1 | 1990 | 283 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1979 | 2043 | 0.000 |
Why?
|
Patient Education as Topic | 1 | 1997 | 2336 | 0.000 |
Why?
|
Palliative Care | 2 | 1983 | 3642 | 0.000 |
Why?
|
Phagocytosis | 1 | 1992 | 1530 | 0.000 |
Why?
|
Dermoid Cyst | 1 | 1987 | 92 | 0.000 |
Why?
|
Dexamethasone | 2 | 1983 | 1964 | 0.000 |
Why?
|
Semustine | 1 | 1984 | 11 | 0.000 |
Why?
|
Patient Satisfaction | 1 | 1997 | 3488 | 0.000 |
Why?
|
Pilot Projects | 1 | 1998 | 8740 | 0.000 |
Why?
|
Drug Synergism | 1 | 1988 | 1760 | 0.000 |
Why?
|
Urinary Fistula | 1 | 1984 | 44 | 0.000 |
Why?
|
Abdominal Neoplasms | 1 | 1985 | 287 | 0.000 |
Why?
|
Running | 1 | 1988 | 490 | 0.000 |
Why?
|
Nephritis | 1 | 1984 | 146 | 0.000 |
Why?
|
Pregnancy | 2 | 1983 | 30260 | 0.000 |
Why?
|
ACTH Syndrome, Ectopic | 1 | 1982 | 30 | 0.000 |
Why?
|
Gonadal Dysgenesis | 1 | 1982 | 28 | 0.000 |
Why?
|
Sigmoid Neoplasms | 1 | 1983 | 54 | 0.000 |
Why?
|
Intestinal Polyps | 1 | 1983 | 105 | 0.000 |
Why?
|
Drug Implants | 1 | 1983 | 230 | 0.000 |
Why?
|
Anorexia | 1 | 1983 | 153 | 0.000 |
Why?
|
Kinetics | 1 | 1990 | 6328 | 0.000 |
Why?
|
Exudates and Transudates | 1 | 1982 | 175 | 0.000 |
Why?
|
Kidney Function Tests | 1 | 1984 | 684 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 1983 | 9116 | 0.000 |
Why?
|
Premedication | 1 | 1982 | 245 | 0.000 |
Why?
|
Pharmacology, Clinical | 1 | 1981 | 23 | 0.000 |
Why?
|
False Negative Reactions | 1 | 1982 | 571 | 0.000 |
Why?
|
Urinary Tract | 1 | 1984 | 305 | 0.000 |
Why?
|
Multiple Myeloma | 1 | 1978 | 5196 | 0.000 |
Why?
|
Metabolism | 1 | 1981 | 193 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1978 | 7470 | 0.000 |
Why?
|
Skin Neoplasms | 1 | 1979 | 5861 | 0.000 |
Why?
|
Alopecia | 1 | 1983 | 416 | 0.000 |
Why?
|
Pulmonary Fibrosis | 1 | 1983 | 506 | 0.000 |
Why?
|
Cholic Acids | 1 | 1978 | 39 | 0.000 |
Why?
|
Chenodeoxycholic Acid | 1 | 1978 | 34 | 0.000 |
Why?
|
Deoxycholic Acid | 1 | 1978 | 54 | 0.000 |
Why?
|
Pelvis | 1 | 1983 | 736 | 0.000 |
Why?
|
Drug Interactions | 1 | 1983 | 1419 | 0.000 |
Why?
|
Drainage | 1 | 1984 | 1183 | 0.000 |
Why?
|
Angiography | 1 | 1983 | 1597 | 0.000 |
Why?
|
Cerebral Infarction | 1 | 1982 | 969 | 0.000 |
Why?
|
Abdomen | 1 | 1983 | 1137 | 0.000 |
Why?
|
Syndrome | 1 | 1983 | 3271 | 0.000 |
Why?
|
Thyroid Gland | 1 | 1983 | 1172 | 0.000 |
Why?
|
Radiotherapy Dosage | 1 | 1983 | 2916 | 0.000 |
Why?
|
Disease Susceptibility | 1 | 1982 | 1793 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1983 | 1280 | 0.000 |
Why?
|
Neoplasms, Experimental | 1 | 1981 | 1230 | 0.000 |
Why?
|
Pedigree | 1 | 1983 | 4539 | 0.000 |
Why?
|
Endoscopy | 1 | 1984 | 1854 | 0.000 |
Why?
|
Forecasting | 1 | 1982 | 2945 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1992 | 18344 | 0.000 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1980 | 957 | 0.000 |
Why?
|
Body Height | 1 | 1978 | 1565 | 0.000 |
Why?
|
Biopsy | 1 | 1982 | 6786 | 0.000 |
Why?
|
Skin | 1 | 1983 | 4503 | 0.000 |
Why?
|
Pain | 1 | 1983 | 5100 | 0.000 |
Why?
|
Body Weight | 1 | 1978 | 4628 | 0.000 |
Why?
|
Head and Neck Neoplasms | 1 | 1980 | 2930 | 0.000 |
Why?
|
Sex Factors | 1 | 1978 | 10627 | 0.000 |
Why?
|
Immunotherapy | 1 | 1979 | 4748 | 0.000 |
Why?
|
Infant | 1 | 1983 | 36534 | 0.000 |
Why?
|
Inflammation | 1 | 1979 | 10871 | 0.000 |
Why?
|
Brain | 1 | 1982 | 27366 | 0.000 |
Why?
|